Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07090590 · ClinicalTrials.gov registry record · NA
Evaluating Feasibility, Acceptability, Usability, and an Initial Estimate of Effect of a Novel Training Platform on Peer Recovery Supporter Skill, Adherence, and Knowledge Gain-Phase I
A NA study, sponsored by Thrive Digital Health.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT07090590: Completed NA study, sponsored by Thrive Digital Health.
NCT07090590 is a NA study that has completed, run by Thrive Digital Health. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07090590, a NA study, has completed, sponsored by Thrive Digital Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This pilot study evaluates the feasibility, usability, and acceptability of the Thrive Digital Peer Platform (TDPP), an online training system for Peer Recovery Support Specialists (PRSS). Twelve participants were enrolled to complete the full TDPP asynchronous curriculum, including self-paced modules, peer-led storytelling, and applied practice activities. The study aimed to assess participant engagement, satisfaction, and perceived relevance of the training to their work as peer supporters. This work represents the Phase I portion of a Fast Track SBIR funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Primary Outcome
Scored performance on videotaped role-play using a modified version of the Yale Adherence and Competence Scale II (YACS II).
Interventions
- BEHAVIORAL Thrive Digital Peer Platform (TDPP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-03-18 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT07090590 record still lists
NCT07090590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Thrive Digital Peer Platform (TDPP) is the first listed.
NCT07090590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07090590 about?
NCT07090590 is a clinical study titled "Evaluating Feasibility, Acceptability, Usability, and an Initial Estimate of Effect of a Novel Training Platform on Peer Recovery Supporter Skill, Adherence, and Knowledge Gain-Phase I". This pilot study evaluates the feasibility, usability, and acceptability of the Thrive Digital Peer Platform (TDPP), an online training system for Peer Recovery Support Specialists (PRSS). Twelve participants were enrolled to complete the full TDPP asynchronous curriculum, including self-paced modul...
What is the current status of trial NCT07090590?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-03-18. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT07090590?
The interventions under investigation include: Thrive Digital Peer Platform (TDPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07090590?
This trial is sponsored by Thrive Digital Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07090590's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI